Shattuck Labs (NASDAQ:STTK – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday, Wall Street Zen reports.
A number of other research analysts also recently issued reports on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Shattuck Labs in a research report on Friday, September 11th. JPMorgan Chase & Co. began coverage on shares of Shattuck Labs in a research note on Friday, July 24th. They issued an “overweight” rating and a $10.00 target price for the company. Wedbush raised their target price on Shattuck Labs from $11.00 to $14.00 and gave the company an “outperform” rating in a report on Friday, October 2nd. HC Wainwright decreased their price target on Shattuck Labs from $18.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, August 11th. Finally, Leerink Partners began coverage on Shattuck Labs in a research note on Monday, July 20th. They set an “outperform” rating and a $16.00 price objective on the stock. Three research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $13.70.
Get Our Latest Analysis on STTK
Shattuck Labs Stock Performance
Shares of Shattuck Labs stock opened at $4.62 on Friday. The company has a fifty day moving average of $6.00 and a 200-day moving average of $6.02. Shattuck Labs has a 52-week low of $1.72 and a 52-week high of $8.33. The stock has a market capitalization of $463.66 million, a price-to-earnings ratio of -9.06 and a beta of 1.21.
Shattuck Labs (NASDAQ:STTK – Get Free Report) last announced its earnings results on Thursday, November 5th. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.04). On average, equities research analysts forecast that Shattuck Labs will post -0.45 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Shattuck Labs
Several large investors have recently added to or reduced their stakes in STTK. Legal & General Group Plc bought a new stake in shares of Shattuck Labs during the second quarter worth approximately $41,000. OMERS ADMINISTRATION Corp raised its stake in Shattuck Labs by 25.7% during the 1st quarter. OMERS ADMINISTRATION Corp now owns 33,300 shares of the company’s stock worth $214,000 after buying an additional 6,800 shares during the period. The Manufacturers Life Insurance Company increased its holdings in Shattuck Labs by 5.4% during the first quarter. The Manufacturers Life Insurance Company now owns 142,300 shares of the company’s stock worth $915,000 after buying an additional 7,244 shares during the last quarter. ProShare Advisors LLC purchased a new stake in Shattuck Labs in the 3rd quarter worth approximately $70,000. Finally, China Universal Asset Management Co. Ltd. lifted its stake in shares of Shattuck Labs by 74.9% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 25,600 shares of the company’s stock valued at $167,000 after acquiring an additional 10,959 shares during the last quarter. Institutional investors and hedge funds own 58.74% of the company’s stock.
Shattuck Labs Company Profile
Shattuck Labs, Inc is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The company’s research is based on its Agonist Redirected Checkpoint (ARC) platform, which is designed to combine immune-cell activation with checkpoint inhibition in a single therapeutic molecule.
Shattuck’s pipeline has included bifunctional fusion proteins such as SL-172154, an investigational therapy designed to engage CD40 ligand and block PD-L1, and SL-173154, which is designed to target CD27 ligand and PD-L1.
Featured Stories
- Five stocks we like better than Shattuck Labs
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Shattuck Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shattuck Labs and related companies with MarketBeat.com's FREE daily email newsletter.
